Evaluating Health Expenditure Trends and Disease Burden in India: A Cost per DALY Approach.

Background: Efficient allocation of healthcare resources requires a comprehensive evaluation of healthcare spending and its impact on disease burden. This study aims to estimate the costs-per disability-adjusted life years (DALY) in India. Data from 2010 to 2019 on DALYs and health expenditure per capita (HEp) for individual states in India were utilised.

Air pollution attributed disease burden and economic growth in India: Estimating trends and inequality between states.

Background: Air pollution is one of the major contributors to the disease burden in India after malnutrition. We examined the relation, and state-wise disparities in air pollution attributed to disease burden (APADB) concerning gross state domestic product (GSDP) and growth in motor vehicles in India.

Methods: We retrieved disability-adjusted life year (DALY) estimates for India due to air pollution from the Global Burden of Disease Studies, injuries, and Risk Factors Study (GBD).

Air Pollution and Cardiovascular Disease Burden: Changing Patterns and Implications for Public Health in India.

Introduction: The link between air pollution-attributed cardiovascular disease (APACVD) burden and its contributing factors can aid in detecting vulnerabilities and providing forewarnings for India.

Methods: We examined the association between the status and trends of the APACVD burden obtained from the Global Burden of Diseases and Injuries study with the two development metrics in India; the human development index (HDI) and indirect indices of economic development, namely annual new motor vehicle registration and the number of functional factories for 10 years from 2009 to 2019. Lorenz curves and concentration index were used to estimate the inequalities in the state-APACVD burden and the burden per 100,000 population.

Incremental net benefit of cholecystectomy compared with alternative treatments in people with gallstones or cholecystitis: a systematic review and meta-analysis of cost-utility studies.

Introduction: Cholecystectomy is a standard treatment in the management of symptomatic gallstone disease. Current literature has contradicting views on the cost-effectiveness of different cholecystectomy treatments. We have conducted a systematic reappraisal of literature concerning the cost-effectiveness of cholecystectomy in management of gallstone disease.